Headquartered in Billerica, MA Fiscal year ends December NASDAQ: BRKR bruker.com
Bruker Corporation (Nasdaq: BRKR) develops and manufactures high-performance scientific instruments and high-value analytical and diagnostic solutions. The company enables scientists and engineers to make post-genomic discoveries and develop applications across life science molecular and cell biology research, specialty diagnostics, applied and biopharma applications, microscopy and nanoanalysis, industrial and cleantech research, and next-generation semiconductor metrology in support of AI. Bruker's product portfolio includes preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, clinical microbiology and molecular diagnostics systems and solutions. The company operates through two main segments: Bruker Scientific Instruments (BSI), which encompasses the BioSpin, CALID, and Nano divisions, and Bruker Energy & Supercon Technologies (BEST). Bruker serves customers in academia, government, biopharma, semiconductor, energy, and industrial markets globally. Updated
Bruker closed at $64.51, a fresh 52-week high that edges 0.26% past the July 30 peak and nearly doubles its March low near $32.71. The $9.8 billion name now has a clean new level for traders to defend.
Arm's 8.5% slide was the deepest move in a 111-stock priority list at Wednesday's close, with Bruker leading the upside at 7.5%.
A 9.6% intraday jump adds close to a billion dollars of market value to a $9.9 billion company in a single session. Moves this size are rare for a life sciences tools name, so watch whether the gain holds into the close.
Bruker holds its nickel quarterly payout for a 10th straight year, unchanged from a year ago. At 0.41%, the yield is a token of consistency rather than income, so the instruments business is the reason to own it.
Cipher Mining closed the session up 10.4% at $16.66, the widest gain across 111 priority names. At the other end, ON Semiconductor gave up 8.9% and Diamondback Energy 7.8%, a roughly 19-point spread between the best and worst names on the day.
Tempus AI closed the session up 10.5%, the only double-digit move among 111 tracked names. The downside was deeper and broader: Axon, Cava and Clover Health all gave up more than 9%.
Pre-Market Stock Futures: The futures are trading higher after NVIDIA Inc. (NASDAQ: NVDA | NVDA Price Prediction) blew out its fiscal third-quarter results and offered strong forward guidance, though perhaps not as…
Bruker Corporation (NASDAQ: BRKR | BRKR Price Prediction) delivered a sharp earnings beat this morning, lifting shares nearly 7% despite underlying headwinds that reveal a company in transition. Non-GAAP EPS of $0.45…
Joel South Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Wednesday’s top analyst upgrades and downgrades included Alliance Data, AvalonBay, Boston Properties, Bruker, Camden Properties and CBRE.
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Boston Beer, Carvana, HD Supply, Marathon Petroleum, Square, Trade Desk and Whirlpool.
The top analyst upgrades, downgrades and initiations seen on Thursday include Advanced Micro Devices, Caterpillar, NRG Energy, Nvidia, Procter & Gamble, Square, Red Hat, Transocean, Viacom and Wisdom Tree.
The top analyst upgrades, downgrades and other research calls from Friday include Activision, Aetna, Apple, Blue Apron, Pandora, Starbucks, Twitter and YogaWorks.
The top analyst upgrades, downgrades and other research calls from Thursday include Agilent Technologies, AT&T, Halcon Resources, HP, International Paper, Seagate technology and Snap.
Over the past five, 10 and 20 years, the life science and bioproduction segments have tended to outperform the S&P 500 more often than not.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Biogen, Discovery Communications, Mosaic, Plains All American, Phillips 66 and Rubicon Project.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Dick's Sporting Goods, Randgold Resources, Royal Dutch Shell, Sysco and Tesla Motors.
Tuesday’s top analyst upgrades, downgrades and initiations include AT&T, Capital One, Cisco, Novartis, Sprint and Starbucks.
The top analyst calls for Thursday include Celgene, DigitalGlobe, Micron Technology, Paychex and Bed Bath & Beyond.
The major money management firms that run exchange traded funds have to do regular quarterly rebalances to reset their portfolios to the proper allocation levels.
ThinkstockThe second-quarter earnings parade may be winding down as we hit August, but the number of companies meeting or exceeding expectations for the period continues to grow. The equity research team at…
Bruker Corporation (Nasdaq: BRKR) develops and manufactures high-performance scientific instruments and high-value analytical and diagnostic solutions.
24/7 Wall St.'s 12-month price target for BRKR is $69.14, rated Buy. The Wall Street consensus target is $62.25. BRKR price prediction →
